本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (5745)
All Articles published online
|
Publishing Process of This Article
|
Jun 9, 2024 (publication date) through Jun 19, 2025
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Clinical Pediatrics
ISSN
2219-2808
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Al-Beltagi M, Saeed NK, Bediwy AS, Elbeltagi R. Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons. World J Clin Pediatr 2024; 13(2): 93341 [PMID: 38948001 DOI: 10.5409/wjcp.v13.i2.93341] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v13/i2/93341.htm |
| 编号 | Citing Articles |
| 1 |
Aysenur Kardas Yildiz, Nafiye Urganci, Ayşe Merve Usta. Evaluation of fecal neutrophil gelatinase‐associated lipocalin levels in childhood inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2025; 80(5): 792 doi: 10.1002/jpn3.70015
|
| 2 |
María Paula Armas-Ingavélez, Edison Arturo Galárraga-Pérez. Utility of fecal calprotectin in the diagnosis of inflammatory bowel diseases. Salud, Ciencia y Tecnología 2025; 5: 1125 doi: 10.56294/saludcyt20251125
|